Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Clinical trial NCT03440372 · TERMINATED
Trial details
- NCT number
- NCT03440372
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2024-10-01
- Enrollment
- 625
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.